A B S T R AC T
Matrix-assisted laser desorption ionization (MALDI)-profiling and imaging mass spectrometry are promising technologies for measuring hundreds of different molecules directly on tissues. For instance, small molecules, drugs and their metabolites, endogenous lipids, carbohydrates and complex peptides/proteins can be measured at the same time without significant disruption of sample integrity. In this review, the potential of MALDI-profiling/imaging technologies in disease proteomics, drug action and studies of cellular processes in the context of kidney tissue is described. Spatial and sequence information obtained in tissue MALDI-profiling/imaging studies can be correlated with other mass spectrometry-based techniques, auxiliary imaging technologies and routine (immuno) histochemical staining.
I N T R O D U C T I O N
Matrix-assisted laser desorption/ionization-mass spectrometry imaging (MALDI-MSI) was first described for protein analysis on intact tissues in 1997 [1] . The technique, which is currently being developed by various groups worldwide, is based on the ability of molecules to form ions when beamed by a laser pulse. Any molecule that is ionized can theoretically be analysed by MSI. This review summarizes the main principles of MALDI-MSI and describes its most important developments in relation to renal disorders.
Detection of protein expression directly on thin sections cut from fresh frozen tissue specimens can be achieved using MS tissue profiling and imaging [2] . MALDI profiling examines the distribution of molecules from preselected regions on a tissue surface and allows comparison of macro-areas of interest within and in between samples. However, prior pathological knowledge is required for proper identification of selected tissue areas, and the method offers only fragmentary analysis. In contrast, MALDI imaging is performed continuously on a whole tissue section and thus, allows for reconstruction of spatial distributions of biomolecules. It offers comprehensive analysis based on redundant measurements per sample, obtained with automated data acquisition and is unbiased (no prior knowledge is required), but involves a significant amount of instrument time for measurements [2] .
The spatial distribution of molecules ( Figures 1 and 2 ) can be further compared with a tissue image obtained with classic (immuno) histochemistry techniques ( Figure 3) .
The MSI technology may be used to 'image' the distribution of hundreds of distinct ion signals and their intensities, with a lateral resolution of ∼20-200 µm and an intensity scale of up to three orders of magnitude [3] . MALDI imaging and profiling methodologies have been successfully used to image cells, plant and animal tissues as well as human specimens [4, 5] . Particularly, studies aimed at characterization of proteins and various biological compounds in normal and diseased tissues [6, 7] have been executed.
Sample handling and preparation of sections for image analysis are critical for spatial and structural integrity of molecular distributions. MALDI-MSI and MALDI-profiling analyses require 10-20-μm thick tissue sections obtained from fresh, flash frozen (or heat pressurized under vacuum) material. Lately, also fixed tissue samples have gained great interest [5, 8] .
Approaches towards protein identification vary on the basis of sample complexity, protein abundance and molecular weight. They can be classified as (i) top-down for analysis of intact proteins directly by tandem MS and (ii) bottom-up approaches where proteins are identified by MS of peptides derived from proteolytic digestion.
I N S T R U M E N TAT I O N
MALDI-TOF instruments are capable of high-throughput imaging with a remarkable resolving power (≥10 μm). Different laser beams have been developed in the last decade: frequency-tripled Nd:YAG, a diode-pumped solid-state laser, F I G U R E 1 : Scheme of MALDI profiling and MALDI-MSI methodologies. Several steps ranging from collection of samples (cells, organs or whole animals), slicing, tissue preparation, matrix deposition, image processing and statistical analyses are shown. In parallel, consecutive sections can be stained using classical (immuno) histology methods. MALDI profiling is performed on localized, 'discrete' regions of the tissue (left panel), while for MALDI-MSI a larger area is scanned (right panel). After processing of the spectra (including baseline correction, smoothingdenoising, peak detection), molecular images of measured m/z can be built (right panel). The clustering algorithms allow for comparisons between different states, i.e. disease versus healthy (left panel). Subsequent analyses might involve tissue microdissection, fractionation, enzyme digestion, MS and MS/MS runs and database searches. Kidney images, courtesy of Bruker Daltonics™.
F U L L R E V I E W
I m a g i n g m a s s s p e c t r o m e t r y which is often used in MALDI mass spectrometers due to its robustness (>10 9 shot lifetime) and high repetition rate [9] or Smartbeam™ (Bruker Daltonics), which combines nitrogen laser performance with the speed and lifetime of Nd:YAG lasers.
For tissue imaging, mass spectrometers must be equipped with an automated rastering and data acquisition system, as well as image reconstruction software. In the last 10 years, several manufacturers have developed mass spectrometers suitable for tissue imaging purposes with 'built-in' software for scanning, image reconstruction and subsequent statistical comparative analyses. An overview of commercial instruments, listing their parameters, can be found at: www.maldimsi.org/.
The mass spectra range for a normal MALDI-TOF imager instrument spans from ∼1 -100 kDa [3, 10, 11] or even 200 kDa [12] . However, in practice, the majority of signals are observed in m/z range <30 kDa. MALDI uses a matrix compound for the ionization of molecules, which in turn creates a high background for detection of small molecules.
T I S S U E M A L D I -M S I A N A LY S I S
Tissue samples: sampling, preparation and storage Ideally, the imaging of a tissue should be a close representation of the in vivo situation [13] . The spatial and chemical integrity of the tissue has to be maintained in all steps, i.e. by fast collection and preparation of the tissue to avoid delocalization/degradation of the analytes [14] . The most critical factors influencing tissue analysis include: (i) tissue treatment after collection, (ii) sectioning and placement of tissues on suitable surfaces and (iii) storage of tissues after sectioning [5, 15] . A comprehensive review on sample handling and tissue preparations is available [16] .
Animals are usually sacrificed by cervical dislocation, after which the tissue of interest is rapidly removed and immediately frozen in liquid nitrogen-cooled isopentane and stored at −80°C until sectioning. This minimizes proteolysis and preserves possible post-translational modifications. Similarly, biopsy/autopsy human material can be stored at −80°C after being subjected to a 'conductive heat transfer' [17] . Alternatively, the tissue may be frozen in a mixture of dry ice and hexane at −75°C, and then embedded in a 2% gel of sodium carboxymethylcellulose [18] .
Contamination with embedding media used for cryosectioning should be avoided as it suppresses ion formation [19] . At present, flash-frozen tissue is usually placed on a cold MALDI target plate or a conductive surface, i.e. a nickel or ITO-coated (indium-tin oxide) glass slide with a minimal amount of optimal cutting temperature (OCT) polymer. The thickness of tissue for MALDI profiling and imaging lies within a range of 5-40 µm; however, for most of the applications, 10-20 µm thin sections are used. While thinner sections are difficult to handle, they provide higher quality mass spectra [20] . Typically, the sample stage temperature is maintained at −15 to −25°C. The cutting temperature depends on the organ; tissue sections with a higher amount of fat (i.e. brain) require lower temperature for optimal cutting. For kidneys, the usual temperature is set at −16°C.
FFPE tissue specimens
Long-term storage of tissue samples is generally achieved by fixation in formalin and embedding in paraffin (FFPE) blocks. Currently, immunohistochemistry is the most sensitive technique which provides anatomical localization data of the peptides/proteins from tissues in FFPE blocks. A drawback of this methodology is that it requires a priori knowledge of the protein/peptide candidates and utilization of specific antibodies which can immunoreact with antigens preserved in the tissue. Stauber et al. [21] developed a strategy for MALDI profiling of archived FFPE tissues, using 6-hydroxydopamine (6-OHDA, a model for Parkinson's disease, PD)-treated rat brain tissues stored in FFPE blocks for several years. MALDI tissue profiling was combined with tryptic in situ tissue enzymatic digestion [21] . On adjacent sections, the identification of compounds was performed by tissue digestion followed by nano-(LC)-MS/MS analyses. The combination of these methodologies enabled confirmation of several known markers of PD and revealed new potential markers of neurodegenerative processes, including the trans-elongation factor 1 and the collapsin response mediator proteins 1 and 2.
Given that cross-linking of the tissue components continues over time, different analytical strategies must be applied for signal recovery. Although direct imaging was possible for tissues preserved for less than a year, poor signal recoveries were observed for samples fixed for longer periods. Thus, for the tissues stored longer than a year, local high-accuracy 'MALDI-MS enzyme-assisted direct analysis' directly on the tissue was suggested, followed by nano-LC-MS identification of the sample mass signals [8] . An example of MALDI-MSI performed on formalin-fixed biopsy material taken 110 years ago from a patient with amyloidosis was recently demonstrated [22] .
MALDI matrices: choice and application One of the major requirements for successful MALDI profiling and MALDI-MSI is the proper incorporation of tissue analytes into a thin matrix layer deposited directly on the tissue and the choice of suitable matrices. In MALDI-profiling experiments, the matrix is applied to discrete spots while for imaging a homogenous layer of matrix is sprayed (spotted) on the tissue (Figures 1 and 2 ).
The choice of an appropriate matrix and compositions of solvents are important for optimized ionization, high-quality mass spectra and for preserving the spatial integrity of the tissue surface [23] . Ionization of high-molecular weight proteins is routinely done by the use of sinapinic acid (SA), while α-cyano-4-hydroxycinnamic acid is commonly used for the analysis of low-molecular weight compounds, such as peptides. DHB-2,5-dihydroxybenzoic acid is mainly suited for profiling experiments (forms larger crystals) and negatively charged molecules with <4 kDa molecular weight.
Before protein/peptide imaging is executed, the tissue needs to be rinsed [2, 24] , to fix proteins and remove contaminants (lipids, endogenous salts and tissue-embedding media). Usually, washing significantly increases (3-to 10-fold) the intensity of observed signals [7] .
The concentration of the matrix is likewise important. Saturated matrix solutions of high concentration (10-30 mg/ mL) were shown to produce better crystals yielding higher ion signals [16] . Solvent combinations and ratios depend on the tissue to be analysed.
The homogeneous application of the matrix on a tissue can be achieved by different ways. These vary from handheld aerosols to automated spray ejectors which offer controlled analyte extraction. Detailed descriptions of various matrices and spraying/spotting techniques have been reported [16] .
Alternatively, Thiery et al. [25] developed TArgeted Multiplex MS IMaging (TAMSIM), utilizing photocleavable mass tags that are covalently coupled to antibodies and can be used as in standard immunohistochemical staining on tissues. With the use of MALDI laser pulses, tags are cleaved off generating ions of known masses, which enable further tracing of the immune-detected structures. TAMSIM can be used to visualize high molecular weight proteins, with archives consisting mostly of FFPE-embedded specimens and target several antigens at the same time. However, it is affected by the antibody cross-reactivity with non-targeted antigens. Data acquisition and processing Morphological comparison of tissues undergoing changes in protein expression due to the disease processes or external stimuli requires the development of different statistical methods.
The selection of differentially expressed proteins results from various data analysis tests. Advanced data analysis algorithms are used for MALDI-MSI datasets. Principal component analysis is a widely used statistical tool [26] . Another unsupervised approach to classify the complex spectra is based on pair-wise clustering according to spectra similarity [27] (Figure 4) . Schwamborn et al. developed [28] an algorithm to distinguish which molecular distributions are correlated within a single MSI dataset and to determine the mass spectral patterns that differentiate cancerous from non-cancerous regions.
Multivariate and hierarchical clustering techniques are used to examine the correlations within a dataset and can reveal differential patterns associated with various organs/ anatomical features. Pair-wise comparisons are usually performed on the training set to identify a subset of differentially expressed protein signals that best separate each classification. For example, based on two independent classification approaches, Weighted Flexible Compound Covariate Method and Survey Documentation and Analysis, the proteomic profiles generated by MALDI MS were used to discriminate between normal brain tissue and gliomas, with high accuracy and precision (92-100%) [29] . Recent reviews describing in detail the instrumentation and software used in various types of MSI can be found elsewhere [30, 31] .
Recognition of molecular signatures
Identification and follow-up of specific cellular alterations within heterogeneous tissues under disease conditions are important. The regions of interest (ROIs) can be defined by histopathology-directed profiling using classic stains that allow for recognition of region-specific 'molecular signatures' [29] .
At present, two different histological staining approaches are utilized: staining on the adjacent sections prior to MALDI imaging or post-analysis on the same sections, which previously underwent MSI, allowing unambiguous matching with the imaging results [28] . While adjacent sections are not identical to the imaged sections, which might be a hindrance for faultless histology/imaging matching, the quality of the recovered staining on the already imaged sections varies (due to possible destruction of epitopes during imaging process) and is based on the remaining integrity of the sample.
Defining regions of specific interest can also be achieved, using i.e. an integrative approach, combining visual specificity of histology with positioning accuracy of the spotter stage to direct placement of matrix onto specific regions of a defined pathogenic profile [4] . Alternatively, the adjacent sections are stained with appropriate antibodies allowing pinpointing ROI [23] and localization of, i.e. Aß plaques in AD brain cortex (Figure 3 ).
M A L D I -M S I A P P L I CAT I O N S
Renal diseases MSI has been successfully utilized to study peptides/proteins, lipids and drugs in animal and human kidneys. Focal segmental glomerulosclerosis was evaluated by protein profiling in a rat model. Control glomeruli from normal tissue and nonsclerotic and sclerotic glomeruli were obtained by laser capture microdissection and analysed by MALDI profiling. The results showed that the proteomic pattern of the nonsclerotic glomeruli was more similar to sclerotic than normal glomeruli. The authors suggested that due to their 'closely related proteomic patterns,' an early activation of prosclerotic mechanisms even in apparently intact glomeruli could be detected [32] .
The pathogenesis of immunoglobulin A (IgA) nephropathy was investigated in an animal model that spontaneously develops mesangioproliferative lesions with IgA deposition, similar to the human disease [33] . The molecular distribution of lipids in hyper-IgA (HIGA) murine kidneys was studied by MSI. For both HIGA and control mice, two F I G U R E 4 : Cluster analysis of the kidney. Separation of Ctsd +/− kidney regions was generated using hierarchical clustering. Based on clustering, three different regions of the kidney can be visualized (in blue-cortex, in yellow-medulla, dark grey-pelvis). Arrows point to identified pelvis foci. The clustering tree was generated using Bruker Daltonics ® ClinProTools ® software (right side).
phosphatidylcholines primarily found in the cortex area and two triacylglycerols predominantly localized in the hilum area were identified. Several other molecules were observed to be over-expressed in the HIGA kidneys when compared with controls. Among those two HIGA-specific molecules, the O-phosphatidylcholine, PC(O-16:0/22:6) and the PC(O-18:1/22:6) could be identified. Tissue distribution and activity of enzymes involved in angiotensin II (Ang II) metabolism were investigated by MALDI-MSI on mouse kidney sections incubated with Ang II. The authors identified the peptides Ang III and angiotensin fragment, Ang-(1-7) as well as a third metabolite, angiotensin fragment Ang- (1-4) , a degradation product of the Ang- (1-7) peptide. Ang III localized to the renal medulla, whereas Ang-(1-7) and Ang-(1-4) predominated in the kidney cortex. Regionally specific peptide formation was confirmed using microdissected biopsies from cortical and medullary regions [34] .
Glycosphingolipids can also be detected by MALDI-MSI. Marsching et al. [35] showed a differential localization of sulfatides with identical ceramide anchors, but different glycansulfate head groups as well as of sulfatides with identical head groups but with different acyl-or sphingoid base moieties in mouse kidneys. They were able to reveal the differential expression of renal sulfatides in sulfatide storing arylsulfatase A-deficient (ASA −/−) mice versus controls [35] .
Cancer research and neurological disorders
The majority of clinical profiling/MSI investigations have been performed on numerous forms of cancers, i.e. brain gliomas [29, 36] , breast [4] , colon [37] , lung [38] , ovarian [39] , prostate cancers [28] as well as in the case of neurological disorders: i.e. Parkinson's and Alzheimer's disease [21, 40, 41] .
Importantly, MALDI profiling can be successfully utilized by clinicians in disease diagnostics. Yanagisawa et al. [38] used MALDI profiling to study protein expression from surgically resected tissues and predicted histological groups and nodal involvement and survival in resected non-small-cell lung cancer. Schwartz et al. [36] studied protein expression patterns in human glial neoplasms and could accurately and reliably identify normal and neoplastic tissues and discriminate between tumours of increasing grades. Another interesting application of MSI was described by Oppenheimer et al. [42] to investigate molecular distributions within a tumour and in the surrounding normal tissue in clear cell renal cell carcinoma. They showed that the histologically normal tissue adjacent to the tumour expresses many of the molecular characteristics of the tumour, such as those of the mitochondrial electron transport system.
A small-scale study involving MSI, in kidney samples with Wilms tumour (WT), the most common malignancy arising in the kidney of children, identified specific peptide profiles from both blastema and stroma that independently classified specimens according to the race with >80% accuracy. The classification of specimens according to the race based on MSI peptide spectra represents an early preview into the biological basis for epidemiologic observations in WT [43] .
Most of the identified proteomic markers for regional node metastasis identified in colon cancer patients using MSI and a label-free quantitative proteomics have not been reported in the context of lymph node metastasis. Three of them (FXYD3, S100A11and GSTM3) were selected for validation using immunohistochemistry and multivariate analysis on an independent cohort, to demonstrate that their expression levels were altered in lymph node metastasis [44] . Such combined approaches can be utilized for screening of novel markers in various tissues and disease conditions.
Monitoring drugs and small molecules Several attempts were made to evaluate the distribution of pharmaceuticals in whole small animal models or different tissues. The localization of the drug 'olanzapine' and two firstpass metabolites in whole-rat sections [45] , qualitative and quantitative analyses of 'erlotinib' (RO0508231) and its metabolites in rat liver, spleen and muscle [46] , analysis of tissue distribution of anticancer drug 'vinblastine' and its product ions in whole body imaging of rats [47] were probed.
MALDI-MSI in combination with quantitative 'whole-body autoradiography' has been successfully used to distinguish whether the measured radioactivity is due to localization of the parent drug or its metabolites in the tissue [47, 48] . In addition, MALDI-MSI is advantageous in early-phase high-throughput drug screens, where it eliminates the necessity of radioactive labelling and monitoring of dozens of drugs.
The MSI technology was also applied to investigate potential toxicity biomarkers in kidneys of rats after 'gentamicin' administration, a well-known nephrotoxicant [49] . Differential protein profiling by a top-down approach showed a protein fragment at 12.959 Da [transthyretin (Ser(28)-Gln(146)] which correlated with histopathological alterations of the kidney. These results clearly demonstrate the potential of MSI in the discovery of toxicity biomarkers and providing insights into the mechanisms of toxicity. Since MSI does not require a molecule to be antigenic for detection, those, for which antibodies cannot be made (i.e. small molecules, drugs) can still be detected during imaging.
Recently MSI was applied to analyse the spatial distribution of the anti-cancer drugs 'imatinib' and 'ifosfamide' in individual mouse organs [50] . The whole kidneys treated with 'imatinib' were scanned at 35 μm spatial resolution followed by one at 10 μm step size in the outer medulla where 'imatinib' displayed a well-defined distribution. The tissue distribution of phospholipids and heme used to characterize the histological features of the tissue section showed an excellent agreement with histological staining of the kidneys. 'Ifosfamide' analysed in mouse kidneys at 20 μm step size was found to be accumulated in the inner medulla region [50] .
L I M I TAT I O N S A N D F U T U R E P E R S P E C T I V E S
Several issues of MALDI-MSI and MALDI-profiling technologies remain to be addressed before they are deemed to be suitable for routine clinical use. One of the major bottlenecks in MALDI imaging is the sample preparation, which is hindered by various disadvantages, i.e. low robustness and poor reproducibility [7] . Moreover, there is a lack of unified methodology that would be applicable to all samples, simplify analysis and minimize errors. The limitations in detection at the higher mass range can be overcome by new sample preparation methods [11] and on-tissue digestion followed by MS/ MS, for detection and identification of proteins with a higher molecular weight (>30 kDa), which cannot be easily ionized/ desorbed. Finally, the development of new tissue protocols regarding tissue analysis or a build-up of more sensitive mass spectrometers might help in detecting protein signals at a higher molecular weight range. Another problem linked to the MALDI-MSI technology is the detection of low abundant proteins.
At present, several research groups worldwide are focusing their efforts on achieving resolutions <10 µm and performance of MALDI-MS measurements in a single cell for a variety of mammalian cell types [22] . Such efforts could expand the utility of this technology towards measurements at a subcellular level.
The MSI technology can also be combined with other imaging techniques (cross correlation analysis [51] ), based i.e. on magnetic resonance imaging (MRI), PET, X-ray, CT instrumentation and optical imaging techniques using fluorescence and bioluminescence readouts. The 3D volume reconstructions generated by MSI data [52] are steps towards comparisons of the molecular data with those obtained using PET or MRI.
Since medical archives of FFPE tissue blocks constitute the vast sample cohorts, current technical development towards identification of signals directly from those tissues represent an important step forward in the utilization of archived material.
Peptides/proteins can be directly identified on tissues, using MS/MS sequencing [22, 53] , especially for abundant molecules. However, for most of the cases, sample enrichment requiring extractions for subsequent LC-MS/MS analyses are still crucial for successful identification. Undoubtedly, direct analysis of signals 'on tissue' will be further developed.
Finally, one possible way to coordinate the current imaging efforts is an establishment of a MALDI-MSI consortium, allowing better coordination of the storage/exchange of data and communication between scientific communities. Furthermore, creating MALDI-MSI databases will allow patterning different tissue specimens, thus permitting development of diagnostics. A step towards this direction is realized by a COST (European Cooperation in Science and technology) action BM1104.
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